Hydrogel maker United-Guardian's Q2 sales rise on cosmetic ingredient demand
UG•Key details
| Metric | Actual |
|---|---|
| Q2 revenue | $3.10 mln |
| Q2 EPS | $0.16 |
- Cosmetic ingredient sales rose 44% in Q2, mainly due to resumed regular purchasing by Ashland Specialty Ingredients after inventory reductions in 2025.
- Pharmaceutical sales rose 1% in Q2, with Renacidin cited as the primary growth driver.
Pharmaceutical sales and outlook
Pharmaceutical sales rose 1% in the second quarter, with Renacidin cited as the main growth driver.
United-Guardian said it is focused on expanding promotional efforts for Renacidin in 2026.
Q2 sales rise on cosmetic ingredient demand
U.S. specialty ingredients maker United-Guardian said its second-quarter net sales rose 10% year over year and net income increased 16%.
Growth was driven by increased cosmetic ingredient sales, mainly from Ashland Specialty Ingredients.
